These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3277255)

  • 1. Commercial uses of recombinant DNA technology in human genetic disease.
    Arnheim N; Erlich HA
    Prog Med Genet; 1988; 7():195-219. PubMed ID: 3277255
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives. Will genome science shift clinical, insurance paradigms?
    Clemmitt M
    Med Health; 2000 Sep; 54(37):suppl 1-4. PubMed ID: 11184793
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic medicine. Powerful opportunities for good and greed.
    Dalzell MD
    Manag Care; 2001 May; 10(5):22-3, 27-8, 33-7. PubMed ID: 11392726
    [No Abstract]   [Full Text] [Related]  

  • 4. Icelandic biotech feels the pinch.
    Wadman M
    Nature; 2008 Oct; 455(7215):842. PubMed ID: 18938257
    [No Abstract]   [Full Text] [Related]  

  • 5. The case for commercial biotechnology in sub-Saharan Africa.
    Gbewonyo K
    Nat Biotechnol; 1997 Apr; 15(4):325-7. PubMed ID: 9094131
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biotechnology, the key to therapeutic innovation in the field of health].
    Hoch D; Tambourin P
    Med Sci (Paris); 2009 May; 25 Spec No 2():13-7. PubMed ID: 19852086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology and the spirit of capitalism.
    Cohen E
    New Atlantis; 2006; 12():9-23. PubMed ID: 16832952
    [No Abstract]   [Full Text] [Related]  

  • 8. The precautionary principle.
    Jank B; Rath J
    Nat Biotechnol; 2000 Jul; 18(7):697. PubMed ID: 10888796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular medicine reaches adulthood in 1999: from the search for the needle in the haystack to genome navigation].
    Biedermann BC
    Schweiz Med Wochenschr; 1999 Dec; 129(51-52):1993-5. PubMed ID: 10674305
    [No Abstract]   [Full Text] [Related]  

  • 10. Empire building: Vienna.
    Smaglik P
    Nature; 2002 Apr; 416(6881):4-5. PubMed ID: 11948307
    [No Abstract]   [Full Text] [Related]  

  • 11. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical genetics problems in the coming years].
    Davidenkova EF
    Klin Med (Mosk); 1982 Mar; 60(3):3-9. PubMed ID: 6953282
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular medicine and information-based targeted healthcare.
    Poste G
    Nat Biotechnol; 1998 May; 16 Suppl():19-21. PubMed ID: 9591257
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequencers step up to the speed challenge.
    Nature; 2006 Sep; 443(7109):258-9. PubMed ID: 16988678
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystal gazing the new biotechnologies.
    Hodgson J
    Nat Biotechnol; 2000 Jan; 18(1):29-31. PubMed ID: 10625386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology in India.
    Ghosh PK
    Australas Biotechnol; 1993; 3(4):214-5, 218-22. PubMed ID: 7764132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotechnology and medicine: ethical concerns.
    Mulherkar R
    Issues Med Ethics; 1997; 5(4):110-1. PubMed ID: 16267904
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA, race, and a new era in medicine.
    Payton M
    JAAPA; 2006 Sep; 19(9):48-9. PubMed ID: 16999287
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology. Bankruptcy won't stop deCODE, says its founder, Stefánsson.
    Kaiser J
    Science; 2009 Nov; 326(5957):1172. PubMed ID: 19965439
    [No Abstract]   [Full Text] [Related]  

  • 20. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.